Skip to main content

Sonelokimab in PsA: Phase 2 Data

Dr. Philip Mease discusses abstract 2582, presented at the 2024 ACR Convergence meeting in Washington, DC.

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.